These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28615111)

  • 1. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
    Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
    Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
    Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
    J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities.
    Kanti Das S; Mishra S; Manna K; Kayal U; Mahapatra S; Das Saha K; Dalapati S; Das GP; Mostafa AA; Bhaumik A
    Chem Commun (Camb); 2018 Oct; 54(81):11475-11478. PubMed ID: 30256355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
    Kushwaha N; Sharma CS
    Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
    Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
    Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review.
    Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A
    Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities.
    Dinh Ngoc T; Moons N; Kim Y; De Borggraeve W; Mashentseva A; Andrei G; Snoeck R; Balzarini J; Dehaen W
    Bioorg Med Chem; 2014 Jul; 22(13):3292-300. PubMed ID: 24844757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
    Verma T; Sinha M; Bansal N
    Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A
    Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
    Brzozowski Z; Saczewski F; Gdaniec M
    Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
    Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
    Zhou X; Lin K; Ma X; Chui WK; Zhou W
    Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of uncondensed 1,2,4-triazines, Part IV. Synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds--an overview.
    Abdel-Rahman RM
    Pharmazie; 2001 Apr; 56(4):275-86. PubMed ID: 11338663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
    Jin GF; Ban HS; Nakamura H; Lee JD
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.